Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors.

[1]  Sun Choi,et al.  A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase , 2016, Scientific Reports.

[2]  L. Meijer,et al.  A Practical Approach to New (5Z) 2-Alkylthio-5-arylmethylene-1-methyl-1,5-dihydro-4H-imidazol-4-one Derivatives , 2011, Molecules.

[3]  A. A. El-Shehawy,et al.  5-Anthracenylidene and 5-(4-Benzyloxy-3-methoxy)benzylidene-hydantoin and 2-Thiohydantoin Derivatives, Synthesis, and S-Alkylation , 2011 .

[4]  G. Kéri,et al.  Small-molecule inhibitors of NADPH oxidase 4. , 2010, Journal of medicinal chemistry.

[5]  Woojin Jeong,et al.  Methods for detection and measurement of hydrogen peroxide inside and outside of cells , 2010, Molecules and cells.

[6]  P. Paneth,et al.  Tautomeric forms study of 1H-(2′-pyridyl)-3-methyl-5-hydroxypyrazole and 1H-(2′-pyridyl)-3-phenyl-5-hydroxypyrazole. Synthesis, structure, and cytotoxic activity of their complexes with palladium(II) ions , 2009, Journal of enzyme inhibition and medicinal chemistry.

[7]  K. Krause,et al.  Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. , 2009, Antioxidants & redox signaling.

[8]  J. Quinn,et al.  Expedient Lewis acid catalyzed synthesis of a 3-substituted 5-arylidene-1-methyl-2-thiohydantoin Library. , 2007, Journal of combinatorial chemistry.

[9]  A. A. Abdalha,et al.  Synthesis of New Thiohydantoin Derivatives Under Phase Transfer Catalysis , 2007 .

[10]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[11]  J. Quinn,et al.  First Example of Lewis Acid Catalyzed 3-Substituted 5-Arylidene-1-methyl-2-thiohydantoin Formation , 2006 .

[12]  S. Rosenkranz,et al.  Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. , 2006, Cardiovascular research.

[13]  Simon J. Walker,et al.  NADPH oxidases in cardiovascular health and disease. , 2006, Antioxidants & redox signaling.

[14]  L. Boulos,et al.  Studies on Phosphonium Ylides-XXIII: The Behavior of Active and Stabilized Phosphonium Ylides Towards Thiohydantoins , 2006 .

[15]  H. Schmidt,et al.  Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. , 2006, Biochemical and biophysical research communications.

[16]  D. Harrison,et al.  Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[17]  W. Lee,et al.  A Direct Role for Dual Oxidase in Drosophila Gut Immunity , 2005, Science.

[18]  P. Hordijk,et al.  Expression and localization of NOX2 and NOX4 in primary human endothelial cells. , 2005, Antioxidants & redox signaling.

[19]  M. Abou-Gharbia,et al.  Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating properties. , 2004, Journal of medicinal chemistry.

[20]  K. Kieć‐Kononowicz,et al.  Antimycobacterial activity of 5-arylidene derivatives of hydantoin. , 2002, Farmaco.

[21]  A. Khodair,et al.  Synthesis of 3-Substituted 5-Arylidene-1-methyl-2-thiohydantoins under Microwave Irradiation , 2002 .

[22]  A. Khodair,et al.  SYNTHESIS, REACTIONS AND CONFORMATIONAL ANALYSIS OF 5-ARYLIDENE-2-THIOHYDANTOINS AS POTENTIAL ANTIVIRAL AGENTS , 2001 .

[23]  S. Galdino,et al.  Synthesis and structural elucidation of new benzylidene imidazolidines and acridinylidene thiazolidines , 2001 .

[24]  T. Burke,et al.  Preparation of aryl isothiocyanates via protected phenylthiocarbamates and application to the synthesis of caffeic acid (4-isothiocyanato)phenyl ester. , 2000, The Journal of organic chemistry.

[25]  L. S. Rice,et al.  Isolation, synthesis, and antitumor evaluation of spirohydantoin aziridine, a mutagenic metabolite of spirohydantoin mustard. , 1986, Journal of medicinal chemistry.

[26]  F. Soroko,et al.  Potential anticonvulsants. 1. 5-Benzylhydantoins. , 1981, Journal of medicinal chemistry.

[27]  G. L. Kenyon,et al.  On the specificity of creatine kinase. New glycocyamines and glycocyamine analogs related to creatine. , 1971, Journal of the American Chemical Society.

[28]  R. A. Jeffreys.  Some reactions of 5-oxothiazolinium merocyanine dyes , 1954 .

[29]  R. A. Jeffreys.  The cyclization of substituted N-thiocarbamoylglycines, and some merocyanine dyes derived from the products , 1954 .

[30]  A. H. Cook,et al.  496. Studies in the azole series. Part XXII. The synthesis of N-alkylamino-acids , 1949 .